Merck Moves Again On Biosimilars
Tuesday, June 14, 2011 - 09:40
in Health & Medicine
Pharmaceuticals: Deal with South Korea's Hanwha adds generic version of Amgen's Enbrel to its portfolio.
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via